Showing results (691-700 of 835) with videos related to

Sort By:
Pageof 84
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomyKatharina Grupp, Mareike Habermann, Hüseyin Sirma, et al.
Psychological Medicine|May 5, 2021
A comparison of self-reported risk and protective factors and the death implicit association test in the prediction of future suicide attempts in adolescent emergency department patientsD A Brent, J Grupp-Phelan, B A O'Shea, et al.
Blood Advances|February 17, 2026
CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multi-site, retrospective cohort reviewAlexander W Rankin, Regina M Myers, Adam J Lamble, et al.
Scientific Reports|November 3, 2025
Establishing and validating syndromic surveillance of gastrointestinal infections using routine emergency department data, Germany, 2019-2023Jonathan Hans Josef Baum, Achim Dörre, Tamara Sonia Boender, et al.
The Prostate|July 12, 2013
SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrenceKatharina Grupp, Franz Diebel, Hüseyin Sirma, et al.
Science (New York, N.Y.)|July 27, 2023
In vivo hematopoietic stem cell modification by mRNA deliveryLaura Breda, Tyler E Papp, Michael P Triebwasser, et al.
Oncology Letters|October 19, 2018
High concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesFranziska Brandi, Katharina Grupp, Claudia Hube-Magg, et al.
Bone Marrow Transplantation|January 22, 2013
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1A E Seif, A Naranjo, D L Baker, et al.
The Journal of Pathology|June 25, 2013
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancersAntje Krohn, Annemarie Seidel, Lia Burkhardt, et al.
Pageof 84